NAKANISHI INC. (7716) Stock Price

Nakanishi manufactures and sells dental medical equipment, dental chairs, and cutting and grinding tools for general industrial use. The Nakanishi Group consists of Nakanishi headquarters and 29 subsidiaries. The business is divided into four segments: Dental, DCI, Surgical, and Machining.

The Dental segment manufactures and sells treatment handpieces, technical micromotor and handpiece units, surgical handpieces, and sterilizers. Major affiliated companies include NSK-AMERICA CORP. and NSK EUROPE GmbH.

The DCI segment manufactures and sells dental chairs. The primary affiliated company in this segment is DCI International, LLC. Dental chairs play an important role in enhancing patient comfort in dental practices.

The Surgical segment manufactures and sells bone cutting equipment used in surgical fields, including neurosurgery. Major affiliated companies include NSK-AMERICA CORP. and NSK EUROPE GmbH. These products are essential for improving the precision and efficiency of surgical procedures.

The Machining segment manufactures and sells hand-operated grinders and machine-mounted spindles. Key affiliated companies in this segment include NSK-AMERICA CORP. and Nakanishi Jaeger GmbH. These products play an important role in industrial cutting and grinding operations.

Since its founding in 1930, Nakanishi has prioritized developing new products tailored to customer needs and has continued to grow in dental care, surgical medicine, and general industrial sectors. The company holds ISO 9001 and ISO 14001 certifications for quality management and promotes environmentally conscious product development. It is particularly focused on strengthening sales and service in Western markets to enhance brand value.

As Nakanishi approaches its 100th anniversary in 2030, it aims to establish a leading position in the global dental and surgical markets by leveraging innovative "cutting technology." The company prioritizes extending healthy life expectancy in an aging society and is focusing on product development that supports dental and overall health. It is also investing in factory automation to address declining labor populations.

Under the medium-term management plan NV2025+, the company is pursuing strategic expansion in the global dental market, with particular focus on increasing market share in dental rotary instruments and implant-related products. It is also advancing business expansion in the Americas and China, improving market share in Europe, and strengthening global after-sales service capabilities.

In the surgical business, the company is expanding its product portfolio and nurturing new businesses through external management resources. To achieve rapid development and cost competitiveness, it is building development and production systems optimized for global deployment and reforming its supply chain.

Nakanishi targets net sales of 55 billion yen, operating profit of 16.5 billion yen, and an operating profit margin of 30%. The company aims for an ROE of 11% and a total shareholder return ratio of 50%. Amid global uncertainties including inflation and rising interest rates, Nakanishi is strengthening its competitive position to succeed in global markets and pursue sustainable growth.